357 related articles for article (PubMed ID: 20649476)
21. Towards a transgenic model of Huntington's disease in a non-human primate.
Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
[TBL] [Abstract][Full Text] [Related]
22. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
Bidollari E; Rotundo G; Ferrari D; Candido O; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Ilari A; Squitieri F; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():145-148. PubMed ID: 29486399
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic mechanisms in Huntington's disease.
Jones L; Hughes A
Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095
[TBL] [Abstract][Full Text] [Related]
24. Derivation of Huntington disease affected Genea020 human embryonic stem cell line.
Dumevska B; Peura T; McKernan R; Goel D; Schmidt U
Stem Cell Res; 2016 Mar; 16(2):430-3. PubMed ID: 27346007
[TBL] [Abstract][Full Text] [Related]
25. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
[TBL] [Abstract][Full Text] [Related]
26. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
[TBL] [Abstract][Full Text] [Related]
27. Multiple phenotypes in Huntington disease mouse neural stem cells.
Ritch JJ; Valencia A; Alexander J; Sapp E; Gatune L; Sangrey GR; Sinha S; Scherber CM; Zeitlin S; Sadri-Vakili G; Irimia D; Difiglia M; Kegel KB
Mol Cell Neurosci; 2012 May; 50(1):70-81. PubMed ID: 22508027
[TBL] [Abstract][Full Text] [Related]
28. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.
Möncke-Buchner E; Reich S; Mücke M; Reuter M; Messer W; Wanker EE; Krüger DH
Nucleic Acids Res; 2002 Aug; 30(16):e83. PubMed ID: 12177311
[TBL] [Abstract][Full Text] [Related]
29. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.
White JK; Auerbach W; Duyao MP; Vonsattel JP; Gusella JF; Joyner AL; MacDonald ME
Nat Genet; 1997 Dec; 17(4):404-10. PubMed ID: 9398841
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of neuronal cell death in Huntington's disease.
Sawa A; Tomoda T; Bae BI
Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190
[TBL] [Abstract][Full Text] [Related]
31. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
[TBL] [Abstract][Full Text] [Related]
32. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.
Sathasivam K; Woodman B; Mahal A; Bertaux F; Wanker EE; Shima DT; Bates GP
Hum Mol Genet; 2001 Oct; 10(21):2425-35. PubMed ID: 11689489
[TBL] [Abstract][Full Text] [Related]
33. Derivation of Huntington Disease affected Genea017 human embryonic stem cell line.
Dumevska B; McKernan R; Goel D; Schmidt U; Peura T
Stem Cell Res; 2016 Mar; 16(2):493-6. PubMed ID: 27346022
[TBL] [Abstract][Full Text] [Related]
34. Haplotype-based stratification of Huntington's disease.
Chao MJ; Gillis T; Atwal RS; Mysore JS; Arjomand J; Harold D; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF; Lee JM
Eur J Hum Genet; 2017 Nov; 25(11):1202-1209. PubMed ID: 28832564
[TBL] [Abstract][Full Text] [Related]
35. Derivation of three clones from human embryonic stem cell lines by FACS sorting and their characterization.
Sidhu KS; Tuch BE
Stem Cells Dev; 2006 Feb; 15(1):61-9. PubMed ID: 16522163
[TBL] [Abstract][Full Text] [Related]
36. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.
Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA
Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478
[TBL] [Abstract][Full Text] [Related]
37. Cells derived from human umbilical cord blood support the long-term growth of undifferentiated human embryonic stem cells.
Zhan X; Hill C; Brayton CF; Shamblott MJ
Cloning Stem Cells; 2008 Dec; 10(4):513-22. PubMed ID: 18823264
[TBL] [Abstract][Full Text] [Related]
38. Advances in huntington disease drug discovery: novel approaches to model disease phenotypes.
Bard J; Wall MD; Lazari O; Arjomand J; Munoz-Sanjuan I
J Biomol Screen; 2014 Feb; 19(2):191-204. PubMed ID: 24196395
[TBL] [Abstract][Full Text] [Related]
39. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation.
Biagioli M; Ferrari F; Mendenhall EM; Zhang Y; Erdin S; Vijayvargia R; Vallabh SM; Solomos N; Manavalan P; Ragavendran A; Ozsolak F; Lee JM; Talkowski ME; Gusella JF; Macdonald ME; Park PJ; Seong IS
Hum Mol Genet; 2015 May; 24(9):2442-57. PubMed ID: 25574027
[TBL] [Abstract][Full Text] [Related]
40. Derivation of embryonic stem cell line from frozen human embryos and neural differentiation.
Tan JC; Li Y; Qu WY; Liu LY; Jiang L; Sun KL
Neuroreport; 2008 Oct; 19(15):1451-5. PubMed ID: 18797296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
